Exponent reported Q1 growth tied to AI-related client work and a mix shift across proactive and reactive engagements. Dr. Catherine Corrigan (President, CEO & Director) said, “Exponent delivered ...
For Q1 2025, total revenues were $145.5M, with net revenues at $137.4M, approximately flat compared to Q1 2024. EBITDA decreased 6% to $37.5M, representing 27.3% of net revenues compared to 29.2% in ...
Catherine Corrigan, the president and CEO of Exponent (NASDAQ:EXPO), reported the sale of 7,821 shares of common stock for approximately $529,000 via open-market transactions between March 16, 2026 ...
The transaction values H&MV at €1.4 billion, a near twelvefold increase since Exponent’s investment in 2022 The CV was oversubscribed and is backed by a consortium of existing and new investors, led ...
The president and CEO of Exponent sold 7,821 shares of common stock for a total transaction value of approximately $529,000 based on a weighted average sale price of $67.59 per share. This sale ...